Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Vaccination vs treatment is a completely false premise. SNG is a treatment for those where the vaccine does work, or people refuse to take it. SNG does compete against vaccines, it competes against the cost of hospitalisation and associated care costs.
M Gormley asked. Do you see Synairgen's inhaled interferon beta as a treatment that will appear on the 2022 landsacpe? or words to that affect/ Perhaps Fruits can remember better then me. I was busy trying to paraphrase everything that was said for the Redditt group as most on there (like here) thought it would be nothing.
As we discussed at length previously, the cost of ICU care is £2000 per night.
Pretty cheap in the grand scheme of things, especially if our drug keeps people out of hospital and/or enables them to return to normal life.
Did he use any overly elaborate analogies as though he was talking to a 5 year old?
Something like Covid ‘is a goalkeeper that can be beaten but SNG would need to get off the sub bench to have a go’
The thing is synairgen isn’t a cheap drug. We know that. Someone correct me but we talking in the region of £2000 per course of tx?
But when you see the cost of intensive care, the long term harm covid causes people, the lives which can potentially be saved and the benefit for not just covid but also in tje fight against future respiratory viruses. Does that price not seem a little more justifiable?
Could anyone state precisely what the question related to SNG was? Thank you.
Spot on Matterhorn. I watched the whole thing. The question made him very uncomfortable and he started talking about targeting patients v cost pretty much. It won't matter when the results get released. The media will do the rest.
He didn't let the words interferon or Synairgen pass through his lips even when that was the question! Not surprised!
*Those receiving oxygen in the hospital setting and potentially those who are breathless in the outpatient setting.
I disagree with the statements made that 1) his comments are not great for SNG and 2) that it's the reason why the US is our target market.
RM made a comment, it was either in the 30 Apr 2021 presentation or in one of his interviews, where he stated the value in discovering breathlessness as a marker to identify which cohort of patients are best to treat. RM clearly understood the value in that and how it'll benefit SNG001 - JVT's comment explained it well. It's also been discussed on the board a number of times.
The cost of a medicine must be justified by the economical benefit it brings to a patient/health service. One of the members gave the specifics behind this calculation and it would actually be good if it can be shared again. If you don't have a target patient group the economical benefit generated by the medicine will be diluted which will have a direct impact on the price you can charge, especially for the more expensive medicines.
In short, we have already passed this test (as explained by JVT) in that we have identified the patient cohort to be treated with SNG001. Those receiving oxygen in the hospital setting and potentially also include those who are breathless in the outpatient setting.
Ukraine.......
Unless you're Merck
potential..... Opened the Bar too early....!!
Taffy, I agree, in the answer to the question about new drugs JVT suggested that a great deal more research will be needed in order to establish who will benefit from those treatments. If the research is not clear, and they expensive, then governments will not pay for their use in the hope that they will work. Lets hope that the SNG research to date will give a clear indication of who will benefit the most.
It should be remembered he can only give a personal view..
He is not a Politician or a decision maker....
We are not looking to the NHS alone...Our potentail market
is world wide..If P3 is successful we have nothing to worry about..
Had to open the Bar early after the market reaction to tensions
in the Ukrainne...... It will blow over..Putin cannot take on the West..
He knows that ....i he s just posturing IMHO!
GLA.. Tomorrow is another day!
Pgmcgra, I’m only giving my opinion as to what JVT said. I’ve been in SNG 18 months, would love it to reach the moon. IMO, JVT saying that with effectiveness ( incl cost) of messenger RNA vaccines, the population of treatments will be reduced. Completely take on board cost of hospitalisations etc, I’m personally just lowering my expectation. Still looking for a good return, but some figs quoted on this bb are b******S.
Brand
You stole my thoughts.
USA won’t put a price on saving lives.
If our drug saves lives, we will see how long before the UK Government jump on it.
Taffy he’s just spouting the usual party line. It would make far more financial sense to vaccinate the clinically vulnerable and have a great lifeline treatment like SNG on the shelf than to vaccinate the entire nation 3 times (and counting) over.
JVT is nothing but a mouthpiece spouting the usual guff.
His answer should inform you of why SNG has gone stateside, further it shows why SNG have targeted hospitalized, breathless patients.
Taffyno1, Do they consider,
What about the cost of hospital stay, far out stay the cost of treatment
Of course he wouldn’t!
Not a good response to SNG question I’m afraid, cost of treatment v vaccination (cheap) effectiveness. I’d say we need to lower expectations.
Quite telling he would not answer specifically ref SNG, and no doubt was ready for it.
Soz Oak, beat me to it ??
We just got a nice mention in the video. Tom Wilko on inhaled Ifb